Horizon Therapeutics in Separate Sale Talks With Amgen, Sanofi, J&J




  • In Business
  • 2022-11-29 23:57:50Z
  • By Bloomberg
 

(Bloomberg) -- Horizon Therapeutics Plc soared in post-market US trading after the developer of medicines for rare autoimmune and inflammatory diseases said it's in talks with a trio of potential suitors about a possible sale of the company.

Most Read from Bloomberg

  • Scientists Revive 48,500-Year-Old 'Zombie Virus' Buried in Ice

  • Banks Stuck With $42 Billion Debt Seize Chance to Offload It

  • These Are the Best and Worst Cities for Expats to Live and Work In

  • This Is Where Luxury Property Prices May Rise and Fall the Most in 2023

  • Apple to Lose 6 Million iPhone Pros From Tumult at China Plant

Amgen Inc., Johnson & Johnson and Sanofi are separately engaged in preliminary discussions with Horizon, the company said in a statement on Tuesday. There's no certainty that any of the talks will lead to an offer. Dublin-based Horizon rose 30% in trading after markets closed in New York.

Emerging from the exhausting focus on Covid-19, big drugmakers are resuming their search for innovative therapies, especially for those that treat rare diseases and cancer. Merck & Co. earlier this year scuttled an estimated $37 billion bid for oncology drugmaker Seagen Inc., though it agreed this month to purchase Imago BioSciences Inc. to gain therapies for rare bone marrow conditions that lead to overproduction of blood cells.

Horizon had dropped 27% this year through Tuesday's close, valuing the company at $17.8 billion. The company gets almost half of its $3.6 billion in annual sales from Tepezza, a treatment for a painful autoimmune condition called thyroid eye disease. Other top drugs include Krystexxa for chronic gout and Ravicti, a treatment for inborn urea disorders.

Horizon is "a premier biotech company that offers significant growth opportunities across both commercialized and pipeline assets," Guggenheim Partners analysts led by Yatin Suneja said in a note. Based on sales estimates, they see a potential deal value of $25 billion to $30 billion.

Under Irish law, each company would have until 5 p.m. New York time on Jan. 10 to either step up with an offer or say it's backing out, Horizon said in the statement. The company has US operations in Deerfield, Illinois, and Rockville, Maryland.

(Updates with analysts' comment on potential deal value in penultimate paragraph.)

Most Read from Bloomberg Businessweek

  • Car Price Divergence Hints at More Painful Inflation Ahead

  • Tesla's Lithium Lead at Risk as Rivals Make Supply Deals

  • How to Keep Your Investments Halal

  • More Men Are Staying Out of the Workforce to Care for Kids

  • Apple's Reliance on China Grows Perilous With Chaos in iPhone City

©2022 Bloomberg L.P.

COMMENTS

More Related News

Meta to Ask Many Managers to Become Individual Contributors or Leave
Meta to Ask Many Managers to Become Individual Contributors or Leave

(Bloomberg) -- Meta Platforms Inc. is asking many of its managers and directors to transition to individual contributor jobs or leave the company as it tries...

What to Look Out for in Biden
What to Look Out for in Biden's Second State of the Union Speech

(Bloomberg) -- President Joe Biden will speak to a joint session of Congress on Tuesday evening against the backdrop of renewed tensions with China and a...

Nomura
Nomura's Japan Staff to Get Bigger Raises as Inflation Quickens

(Bloomberg) -- Nomura Holdings Inc. will give its employees in Japan bigger pay raises starting in April, citing intensifying competition for talent and...

Quake Latest: Turkish Rescuers Race Against Time in Cold Weather
Quake Latest: Turkish Rescuers Race Against Time in Cold Weather

(Bloomberg) -- Most Read from BloombergQuake Toll Hits 4,000 in Turkey, Syria as Overseas Aid FlowsTurkey's South Hit by a Second High-Magnitude...

Biggest South Africa Cement Firm Mulls Sale of Zimbabwe Unit
Biggest South Africa Cement Firm Mulls Sale of Zimbabwe Unit

(Bloomberg) -- PPC Ltd., South Africa's largest cement maker, is considering selling its Zimbabwe business for about $200 million, according to people with...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Business